Select Medical Holdings (SEM) Net Income towards Common Stockholders (2018 - 2026)

Select Medical Holdings (SEM) has 9 years of Net Income towards Common Stockholders data on file, last reported at $63.8 million in Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 120.08% year-over-year to $63.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$893.2 million (down 73.97% YoY) and the FY2025 annual result came in at -$311.3 million, down 98.3% from the prior year.
• Net Income towards Common Stockholders advanced to $63.8 million in Q1 2026 per SEM's latest filing, from -$311.3 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $66.3 million in Q2 2022 and bottomed at -$376.4 million in Q4 2022.
• The 5-year median for Net Income towards Common Stockholders is $39.7 million (2024), against an average of -$95.7 million.
• The widest annual swing landed in 2025, when Net Income towards Common Stockholders tumbled 910.12%; it then surged 120.08% in 2026.
• Tracing SEM's Net Income towards Common Stockholders over 5 years: stood at -$376.4 million in 2022, then surged by 39.46% to -$227.9 million in 2023, then declined by 27.86% to -$291.4 million in 2024, then dropped by 6.86% to -$311.3 million in 2025, then jumped by 120.48% to $63.8 million in 2026.
• Per Business Quant, the three latest SEM Net Income towards Common Stockholders figures stand at $63.8 million (Q1 2026), -$311.3 million (Q4 2025), and -$321.9 million (Q3 2025).

Peer Comparison